The invasiveness and migration capacity of breast tumor cells are currently known to correlate with ER expression, and in this study, we confirmed that breast cancer treatment was the most effective with an essential balance of the ERα+/ERα− ratio status. The gene discussed is ESR1; the disease is breast carcinoma.